product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
Phospho-PP1α (Thr320) Antibody
catalog :
2581
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
antigen modification :
phosphorylated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunohistochemistry - paraffin section
citations: 3
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry; rat; loading ...; fig 3c
Doré K, Carrico Z, Alfonso S, Marino M, Koymans K, Kessels H, et al. PSD-95 protects synapses from β-amyloid. Cell Rep. 2021;35:109194 pubmed publisher
  • western blot; mouse; loading ...; fig s4h
Lu Y, Kavianpour S, Zhang T, Zhang X, Nguyen D, Thombre R, et al. MARK2 phosphorylates eIF2α in response to proteotoxic stress. PLoS Biol. 2021;19:e3001096 pubmed publisher
  • western blot; human; loading ...; fig 5f
Wang H, Chen Z, Wang S, Gao X, Qian M, Qiu W, et al. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas. Mol Oncol. 2020;14:407-425 pubmed publisher
product information
SKU :
2581S
Product-Name :
Phospho-PP1α (Thr320) Antibody
Size :
100 ul
Price-(USD) :
274 USD
Species-x-Reactivity :
H, M, R, Mk
Applications :
Immunohistochemistry (Paraffin)
Product-Category :
Cell Cycle / Checkpoint Control
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
38
Host :
Rabbit
Target :
PP1a (Thr320) phosphate
Primary-Protein :
PPP1CA
Alt-Names :
MGC15877,MGC1674,PP-1A,PP1A,PP1alpha,PPP1A,PPP1CA,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,protein phosphatase 1, catalytic subunit, alpha isoform,protein phosphatase 1, catalytic subunit, alpha isozyme,serine/threonine protein phosphatase PP1-alpha 1 catalytic subunit
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.